These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2988126)

  • 41. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.
    Mazier D; Mellouk S; Beaudoin RL; Texier B; Druilhe P; Hockmeyer W; Trosper J; Paul C; Charoenvit Y; Young J
    Science; 1986 Jan; 231(4734):156-9. PubMed ID: 3510455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion.
    Rathore D; Nagarkatti R; Jani D; Chattopadhyay R; de la Vega P; Kumar S; McCutchan TF
    J Biol Chem; 2005 May; 280(21):20524-9. PubMed ID: 15781464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of an engineered internal image antibody.
    Billetta R; Hollingdale MR; Zanetti M
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4713-7. PubMed ID: 1905014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of immunogens for synthetic malaria vaccines.
    Lise D; Dubeaux C; Tello D; Mazier D; Jolivet M; Schlesinger DH; Audibert F; Chedid L
    Biochem Biophys Res Commun; 1988 May; 153(1):31-8. PubMed ID: 3288205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides.
    Lowell GH; Ballou WR; Smith LF; Wirtz RA; Zollinger WD; Hockmeyer WT
    Science; 1988 May; 240(4853):800-2. PubMed ID: 2452484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The main obstacle to a malaria vaccine: the malaria parasite.
    Miller LH; Good MF
    Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope.
    Enea V; Ellis J; Zavala F; Arnot DE; Asavanich A; Masuda A; Quakyi I; Nussenzweig RS
    Science; 1984 Aug; 225(4662):628-30. PubMed ID: 6204384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope.
    Arnot DE; Barnwell JW; Tam JP; Nussenzweig V; Nussenzweig RS; Enea V
    Science; 1985 Nov; 230(4727):815-8. PubMed ID: 2414847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages.
    Chaves F; Calvo JC; Carvajal C; Rivera Z; Ramírez L; Pinto M; Trujillo M; Guzmán F; Patarroyo ME
    J Pept Res; 2001 Oct; 58(4):307-16. PubMed ID: 11606215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli.
    Wirtz RA; Ballou WR; Schneider I; Chedid L; Gross MJ; Young JF; Hollingdale M; Diggs CL; Hockmeyer WT
    Exp Parasitol; 1987 Apr; 63(2):166-72. PubMed ID: 3552712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.
    White K; Krzych U; Gordon DM; Porter TG; Richards RL; Alving CR; Deal CD; Hollingdale M; Silverman C; Sylvester DR
    Vaccine; 1993 Oct; 11(13):1341-6. PubMed ID: 7507624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity of the nonrepetitive regions of the circumsporozoite protein of Plasmodium knowlesi.
    Sharma S; Goswami A; Singh NJ; Kabilan L; Deodhar SS
    Am J Trop Med Hyg; 1996 Dec; 55(6):635-41. PubMed ID: 9025690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.